Skip to content
IV Injection Allopathic

Decitabine-Sun 50 mg/vial iv injection

Generic: Decitabine

Company: Sun Pharmaceutical (Bangladesh) Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength50 mg/vial
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated August 18, 2025.

Compare

Same generic, same strength

Sorted by price per iv injection. Ask your pharmacist before you switch brands.

Decitabine 50 mg/vial iv injections

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Decitabine guide

Indications

Decitabine is indicated for treatment of adult patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.

Dosage and administration

Three Day Regimen: Administer DACOGEN at a dose of 15 mg/m2 by continuous intravenous infusion over 3 hours repeated every 8 hours for 3 days. Repeat cycles every 6 weeks upon hematologic recovery (ANC at least 1,000/µL and platelets at least 50,000/µL) for a minimum of 4 cycles. . A complete or partial response may take longer than 4 cycles. Delay and reduce dose for hematologic toxicity Five Day Regimen: Administer DACOGEN at a dose of 20 mg/m2 by continuous intravenous infusion over 1 hour daily for 5 days. Delay and reduce dose for hematologic toxicity (see Dose Modifications for Toxicity). Repeat cycles every 4 weeks upon hematologic recovery (ANC at least 1,000/µL and platelets at least 50,000/µL) for a minimum of 4 cycles. A complete or partial response may take longer than 4 cycles.

Side effects

Most common adverse reactions (>50%) are neutropenia, thrombocytopenia, anemia, and pyrexia.

Precautions and warnings

Neutropenia and thrombocytopenia: Perform complete blood counts and platelet counts. Embryo-fetal Toxicity: Can cause fetal harm. Advise patients of reproductive potential of the potential risk to a fetus and to use effective contraception.

Pregnancy and lactation

Based on findings from human data, animal studies, and the mechanism of action, Decitabine can cause fetal harm when administered to a pregnant woman. Advise not to breastfeed. There are no data on the presence of decitabine or its metabolites in human milk, the effects on the breastfed child, or the effects on milk production.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250